Authors
Loading...
Research reveals dominant-negative mutation in DDX41 impacts non-truncating variants in patients with hematopoietic disorders.
Stepanchick et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: